BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15370560)

  • 1. Proteomic analysis of cholesteatoma.
    Kim JL; Jung HH
    Acta Otolaryngol; 2004 Sep; 124(7):783-8. PubMed ID: 15370560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Protein Expression in Congenital and Acquired Cholesteatomas.
    Shin SH; Huang M; Kim SH; Choi JY
    PLoS One; 2015; 10(9):e0137011. PubMed ID: 26335306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesteatoma growth and proliferation: relevance with serpin B3.
    Ho KY; Huang HH; Hung KF; Chen JC; Chai CY; Chen WT; Tsai SM; Chien CY; Wang HM; Wu YJ
    Laryngoscope; 2012 Dec; 122(12):2818-23. PubMed ID: 23239141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained extracellular signal-regulated kinase1/2 mitogen-activated protein kinase signalling is related to increased p21 expression in cholesteatoma epithelium.
    Huisman MA; De Heer E; Grote JJ
    Acta Otolaryngol; 2005 Feb; 125(2):134-40. PubMed ID: 15880942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in acquired middle ear cholesteatoma growth.
    Ho KY; Yeh TS; Huang HH; Hung KF; Chai CY; Chen WT; Tsai SM; Chang NC; Chien CY; Wang HM; Wu YJ
    Int J Mol Sci; 2013 Jul; 14(7):14439-59. PubMed ID: 23852020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terminal differentiation and mitogen-activated protein kinase signaling in human cholesteatoma epithelium.
    Huisman MA; De Heer E; Grote JJ
    Otol Neurotol; 2006 Apr; 27(3):422-6. PubMed ID: 16639284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclast stimulating and differentiating factors in human cholesteatoma.
    Hamzei M; Ventriglia G; Hagnia M; Antonopolous A; Bernal-Sprekelsen M; Dazert S; Hildmann H; Sudhoff H
    Laryngoscope; 2003 Mar; 113(3):436-42. PubMed ID: 12616193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis of human middle ear cholesteatoma using complementary DNA arrays.
    Tokuriki M; Noda I; Saito T; Narita N; Sunaga H; Tsuzuki H; Ohtsubo T; Fujieda S; Saito H
    Laryngoscope; 2003 May; 113(5):808-14. PubMed ID: 12792315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentially expressed proteins of gamma-ray irradiated mouse intestinal epithelial cells by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.
    Zhang B; Su YP; Ai GP; Liu XH; Wang FC; Cheng TM
    World J Gastroenterol; 2003 Dec; 9(12):2726-31. PubMed ID: 14669322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry.
    Vanrobaeys F; Van Coster R; Dhondt G; Devreese B; Van Beeumen J
    J Proteome Res; 2005; 4(6):2283-93. PubMed ID: 16335977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of differentially expressed proteins of gamma-ray irradiated rat intestinal epithelial IEC-6 cells by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry.
    Bo Z; Yongping S; Fengchao W; Guoping A; Yongjiang W
    Proteomics; 2005 Feb; 5(2):426-32. PubMed ID: 15700242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of beta-defensins in human middle ear cholesteatoma.
    Park K; Moon SK; Choung YH; Choi HS
    Acta Otolaryngol; 2003 Jan; 123(2):236-40. PubMed ID: 12701748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.
    Shieh TJ; Ho KY; Kuo WR; Chai CY; Lin CS; Juan KH
    Kaohsiung J Med Sci; 1999 Aug; 15(8):468-74. PubMed ID: 10518363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells.
    Vercoutter-Edouart AS; Czeszak X; Crépin M; Lemoine J; Boilly B; Le Bourhis X; Peyrat JP; Hondermarck H
    Exp Cell Res; 2001 Jan; 262(1):59-68. PubMed ID: 11120605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of plasma from cows affected with milk fever using two-dimensional differential in-gel electrophoresis and mass spectrometry.
    Xia C; Zhang HY; Wu L; Xu C; Zheng JS; Yan YJ; Yang LJ; Shu S
    Res Vet Sci; 2012 Oct; 93(2):857-61. PubMed ID: 22119234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and comparative proteomic study of quail and duck egg white protein using 2-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry analysis.
    Hu S; Qiu N; Liu Y; Zhao H; Gao D; Song R; Ma M
    Poult Sci; 2016 May; 95(5):1137-44. PubMed ID: 26957635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on epidermal proliferation ability in cholesteatoma.
    Tanaka Y; Shiwa M; Kojima H; Miyazaki H; Kamide Y; Moriyama H
    Laryngoscope; 1998 Apr; 108(4 Pt 1):537-42. PubMed ID: 9546266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression in cholesteatoma by DNA chip analysis.
    Macias JD; Gerkin RD; Locke D; Macias MP
    Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix assisted laser desorption/ionization-time of flight-mass spectrometry analysis of proteins detected by anti-phosphotyrosine antibody on two-dimensional-gels of fibrolast cell lysates after tumor necrosis factor-alpha stimulation.
    Yanagida M; Miura Y; Yagasaki K; Taoka M; Isobe T; Takahashi N
    Electrophoresis; 2000 May; 21(9):1890-8. PubMed ID: 10870974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.